FDA approves next-gen MicroPort CRM pacemakers

The Alizea pacemaker. [Image from MicroPort CRM]MicroPort CRM announced today that it received FDA approval for its Alizea and Celea implantable pacemakers.

The cardiac rhythm management subsidiary of MicroPort Scientific said its newly approved devices are the longest-lasting pacemakers for their size on the market today. They offer a volume of just 11cc and a projected longevity of 13 years.

Additionally, the company also received approval for the associated Vega pacing leads, SmartTouch XT tablet-based programmer and SmartView Connect Bluetooth home monitor.

MicroPort CRM said it marks a “significant achievement” for patient care. It also demonstrates the Clamart, France-based company’s commitment to the U.S. market.

“MicroPort CRM has always been committed to providing medical devices with the most advanced technology and features to improve patient outcomes and reduce the burden on the healthcare system”, said Benoît Clin…

Read more
  • 0